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iliac interventions (CIA and EIA), race, age, and EIA occlusion all impacted
primary patency. This study emphasizes the underappreciated effect of pa-
tient demographics and lesion severity on stenting outcomes.
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Redeﬁning the Operative Threshold in Women With Abdominal
Aortic Aneurysms
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Introduction: Rupture of an abdominal aortic aneurysm (AAA) is a
usually fatal event best prevented by timely diagnosis and surgical interven-
tion. Evidence is accumulating that women tend to rupture AAAs at smaller
sizes than men, are often at higher risk because of age and comorbidities,
and have poorer outcomes. In the past, women were often excluded from
lower-risk endovascular aortic aneurysm repair (EVAR) because of inade-
quate iliac vascular access. Furthermore, current elective operative recom-
mendations for asymptomatic AAA repair of >5.5 cm do not distinguish
possible differences between men and women regarding the advantages of
earlier treatment with respect to the risk of rupture relative to AAA size.
Methods: All patients evaluated with International Classiﬁcation of
Diseases-9th Revision diagnosis codes for AAAs at a single institution be-
tween 2000 and 2012 were identiﬁed for retrospective analysis under Inves-
tigational Review Board approval.
Results: A total of 3800 patients were identiﬁed with a diagnosis of
AAA. Of these, there were 3686 patients (97%) with nonruptured AAAs
and 114 patients (3%) with ruptured AAAs. The male-to-female ratios for
nonruptured and ruptured AAAs were similar (2.9:1 and 2.5:1, respectively)
as were the percentages of ruptured AAAs for men and women (2.9% and
3.4%, respectively). Also similar were jospital mortality rates for ruptured
AAAs in men (42.0%) and women (42.4%). AAA diameter at the time of
rupture was determined in 75 patients (54 men and 21 women). The mean
ruptured AAA diameter was 7.9 6 1.6 cm (range, 4.5-12.0 cm) for men
and 6.5 6 1.5 cm (range, 3.6-9.0 cm) for women. Of the ruptured AAA pa-
tients, 97.3% were treated with emergency open AAA repair and 2.7% by
emergency EVAR. The percentage of patients with a ruptured AAA
<5.5 cm in diameter was 28.6% for women and only 3.7% for men (Fig).
Conclusions: Although this single-institution experience is small, these
results strongly indicate that AAAs in women tend to rupture at smaller diame-
ters than men. Mortality for elective EVAR has dramatically decreased AAA
operative risk, and the newer low-proﬁle delivery systems have made this tech-
nology routinely available for women. Current recommendations for elective
operative intervention forAAAs shouldbe reconsidered and stratiﬁedbygender.Fig. Percentage rupture with 5.5-cm threshold.
Fig 1. A, Vein graft computed tomography (CT) cross-sectional area vs ul-
trasound (U/S) velocity. B, Vein graft CT stenosis ratio vs U/S velocity ratio.Author Disclosures: A. Skibba: None; J. Evans: None; S. Hopkins:
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Background: Infrainguinal vein graft bypass has 5-year patency rates
between 45 and 80%, and the optimal post-operative approach to graft sur-
veillance is not clear. The current study was designed to evaluate the rela-
tionship between physiologic (duplex scanning) and anatomic (CT scan)
methodologies for assessment of vein graft stenosis and evaluate the rela-
tionship of these observed abnormalities to vein graft failure.
Methods: Fifty-four patients who underwent infrainguinal autogenous
vein graft bypass for disabling claudication or tissue loss at the Malcolm Ran-
dall Veterans Affairs Medical Center in Gainesville, Florida were included in
our study. These patients were followed with concurrent duplex U/S andCT
imaging at intervals of 1 week, 1 month, 6 months, and 12 months postop-
eration. For each of the “zones” within the bypass graft (we divide the leg
into six zones), and U/S peak-systolic velocity and mean CT cross-sectional
area were calculated. Thus, our initial data set consisted of both an U/S ve-
locity measurement and a CT cross-sectional area measurement for each zone
per patient, at each of the four time points for a total of 656 patient*zone*-
time points (Fig 1, A). We also transformed these 656 sets of CT and U/S
data into CT percent stenosis and U/S velocity ratios.
Results: A CT stenosis less than 50% was extremely highly correlated
with success (0% failure), while a velocity ratio > 3.5 was correlated with a
67% failure rate (Fig 1, B; Table). Interestingly, even high degrees of CT
demonstrated stenosis were still more likely to succeed than not, with those
in the >80% group having only a 25% failure rate (Table). Those zones with
moderate graft stenosis, identiﬁed as a duplex-derived velocity ratio in the
2.0 to 3.5 range, tended to improve with time as 78% showed a reduction
in the velocity ratio at the next time interval (Fig 2). Importantly, within this
group only a 12% failure rate was seen, thus demonstrating the relatively
benign nature of this degree of stenosis (Table).
Fig 2. Ultrasound (U/S) velocity ratio progression over time.
Table. Relationship of duplex and computed tomography (CT) scan
ﬁndings and graft failure
Graft status
P valueFailed, No. (%) Patent, No. (%)
U/S velocity ratio
<2.0 3 (0.5) 622 (99.5) <.001a
2.0-3.5 3 (12) 22 (88)
>3.5 4 (67) 2 (33)
CT stenosis
0-49% 0 (0) 578 (100) <.001a
50-59% 2 (5) 35 (95)
60-69% 5 (22) 18 (78)
70-79% 2 (14) 12 (86)
>80% 1 (25) 3 (75)
U/S, Ultrasound.
aFisher’s exact test.
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Volume 60, Number 6 Abstracts 1717Conclusions: Our analysis demonstrates that signiﬁcantly elevated
U/S velocity ratios >3.5 are strongly correlated with graft failure and also
that low and even moderate CT stenosis correlate with graft success. We
show that a moderately elevated U/S velocity ratio in the 2 to 3.5 range
is largely clinically benign, with few of these grafts ultimately failing and
that velocity ratios for this group tend to improve with time. This is a
step toward deﬁning the relationship between imaging and outcome for
vein grafts, an understanding of which will likely contribute to the establish-
ment of the optimal strategy for graft monitoring.
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Outcomes of Infected Abdominal Aortic Endografts: A Multicenter
Experience
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Introduction: Limited single-center experiences with the treatment
of infected endovascular endografts (I-EVAR) have been reported. We per-
formed a multicenter review of the surgical care of these patients to eluci-
date short-term and long-term outcomes.
Methods: A retrospective analysis of all EVAR explants from 2000 to
2014 at four institutionswas performed. Patients with I-EVAR undergoing sur-
gical treatmentwere reviewed.Datawereobtaineddetailingpreoperative patient
demographics, postoperativemorbidity andmortality, and long-term follow-up.
Results: Thirty-six patients, 30 male (83%) and six female (17%), with a
median age of 69 years (range, 54-80 years), were treated with endovascular
graft excision and revascularization for I-EVAR. Average time from initial
EVAR to explantation was 589 days (range, 43-2466 days). Preoperativecomorbidities include hypertension, 32 (89%); tobacco use, 31 (86%); coro-
nary artery disease, 26 (72%); hyperlipidemia, 25 (69%); peripheral arterial dis-
ease, 13 (36%); cerebrovascular disease, 10 (28%); diabetes, 10 (28%); chronic
obstructive pulmonary disease, 9 (25%); and chronic kidney disease, 9 (25%).
The most common presenting symptoms were leukocytosis in 23 (63%), pain
in 21 (58%), and fever in 20 (56%), which were present an average of 22 days
prior to explantation. Eight different types of endograft were removed. Three
patients (8%) underwent emergency explantation. Thirty-two patients under-
went total graft excision (89%), and four patients underwent partial excision
(11%). Methods of reconstruction included in situ reconstruction in 25
(69%) and extra-anatomic reconstruction in 11 (31%). Conduits used in
reconstruction consisted of Dacron, with or without rifampin treatment, poly-
tetraﬂuoroethylene, cryopreserved allograft, and superﬁcial femoral vein.
Forty-nine organisms grew from operative cultures. Gram-positive organisms
were the most common isolate found in 32 (88%), including Staphylococcus in
12 (33%), and Streptococcus in six (17%). Anaerobic organisms were cultured
in 11 patients (31%), gram-negative organisms in 8 (22%), and fungus in 5
(14%). Amajority of patients (21 [58%]) were treated with long-term suppres-
sive antibiotic therapy. Early complications included acute renal failure in 12
(33%), respiratory failure requiring tracheostomy in 3 (8%), bleeding in 2
(6%), and sepsis in 2 (6%). Six patients required reexploration due to hema-
toma, infected hematoma, lymphatic leak, small-bowel perforation, open
abdomen at initial operation, and anastomotic bleeding. Perioperative mortal-
ity was 8% (3 of 36) and overall mortality was 25% (9 of 36) at a mean follow-
up of 402 days (range, 0-2472 days). Type of reconstruction (in situ vs extra-
anatomic) or conduit type did not affect perioperative or overall mortality.
Conclusions: I-EVAR is a rare but potentially devastating clinical
problem. Although perioperative mortality is acceptable, overall mortality
is high. The most common postoperative complication was acute renal fail-
ure; therefore, aortic cross-clamp time should be minimized. Although this
is the largest series of I-EVAR, further studies will be necessary to under-
stand risk factors and preventive measures.
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The Aorﬁx AAA Endograft in Highly Angulated Aortic Necks:
Performance in the Pythagoras U.S. Clinical Trial
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Introduction: The AORFIX endograft (Lombard Medical) is a highly
conformablemodular nitinol/polyester device designed for infrarenal or trans-
renal ﬁxation. PYTHAGORAS is the ﬁrst clinical trial to evaluate outcomes for
EVAR using AORFIX in highly angulated infrarenal aortic necks ($60).
Methods: PYTHAGORAS is a prospective nonrandomized clinical
trial that enrolled and treated 151 patients with neck angles $60 (high-an-
gle) and 67 patients with neck angles <60 (low-angle) in the EVAR group.
The primary control group was patients concurrently undergoing open repair
(n ¼ 76), and a meta-analysis of 323 patients from U.S. EVAR clinical trials
(Society for Vascular Surgery Lifeline) served as the secondary control. We
compared the high- and low-angle EVAR groups with the open group in
PYTHAGORAS in terms of mortality (30-day and 1-year) and freedom
from major adverse events (MAEs) deﬁned by the Society for Vascular Sur-
gery (myocardial infarction, cerebrovascular accident, renal failure, respira-
tory failure, paralysis/paraparesis, bowel ischemia, death, and bleeding)
using the Fisher exact test (Table I). Graft migration and type I and III endo-
leak were compared between high-angle and low-angle groups (Table II).
Results: Patient demographics and comorbidities were similar be-
tween the EVAR and open group with the exception of age (EVAR 76 6
8 vs open 70 6 7 years; P < .05), congestive heart failure (EVAR 13% vs
open 7% P ¼ .015), neck angle (EVAR all 71 6 23 and high angle 83
6 15 vs open 48 6 23; P < .05), and female gender (EVAR high angle
35% vs open 17%; P < .0001). Sac diameter and other anatomic variables
were similar. Operative data favored the EVAR group for procedure dura-
tion, blood loss, and hospital length of stay (all P < .05). There was no
statistically signiﬁcant difference between freedom from MAEs, 30-day,
and 1-year mortality between of low-angle or high-angle EVAR groups
compared with the PYTHAGOAS open control group (Table I). Also, there
was no difference between low-angle and high-angle patients in regards to
sac shrinkage, type I/III endoleak, and endograft migration (Table II).
Conclusions: PYTHAGORAS is the ﬁrst U.S. clinical trial designed
to evaluate the performance of EVAR in a population of patients with
neck angles $60. Despite signiﬁcant predictors of worse short-term and
long-term outcomes (female gender, congestive heart failure, neck angle),
MAEs and other pertinent outcomes were better or similar to open repair
